Brenntag (OTCMKTS:BNTGY – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.28), Zacks reports. The company had revenue of $4.09 billion for the quarter, compared to analyst estimates of $4.22 billion. Brenntag had a return on equity of 5.88% and a net margin of 1.71%.
Brenntag Trading Down 0.4%
Shares of BNTGY opened at $11.12 on Friday. The company’s 50 day simple moving average is $12.09 and its 200-day simple moving average is $11.76. The firm has a market cap of $8.03 billion, a PE ratio of 27.12 and a beta of 0.75. Brenntag has a 12-month low of $10.19 and a 12-month high of $14.50.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on BNTGY shares. Morgan Stanley cut shares of Brenntag from an “equal weight” rating to an “underweight” rating in a report on Tuesday, January 6th. Citigroup reiterated a “neutral” rating on shares of Brenntag in a research note on Friday, November 14th. Finally, Barclays upgraded shares of Brenntag to a “hold” rating in a research note on Thursday, January 15th. Six analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of $12.80.
Brenntag Company Profile
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Read More
- Five stocks we like better than Brenntag
- A personal warning from Martin Weiss (Please read)
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
